作者: Lisa V. Kalman , Ira M. Lubin , Shannon Barker , Desiree du Sart , Rob Elles
DOI: 10.5858/ARPA.2012-0311-RA
关键词: Test performance 、 Medicine 、 Clinical tests 、 Laboratory Proficiency Testing 、 External quality assessment 、 Proficiency testing 、 Scope (project management) 、 Engineering management 、 Molecular genetic testing 、 Quality (business)
摘要: Context.—Participation in proficiency testing (PT) or external quality assessment (EQA) programs allows the and comparison of test performance among different clinical laboratories technologies. In addition to approximately 2300 tests for individual genetic disorders, recent advances technology have enabled development that quickly economically analyze entire human genome. New PT/EQA approaches are needed ensure continued these complex tests. Objectives.—To review availability scope molecular inherited conditions Europe, Australasia, United States; evaluate successes demonstrated value available programs; examine challenges provision comprehensive posed by new laboratory practices methodologies. Data Sources.—The literature on this topic was reviewed supplemented with personal experiences several providers. C...